Roche Submits Breast-Cancer Drug to FDA - WSJ.com Pharmaceutical company Roche has submitted an application to the U.S. FDA for its antibody-drug trastuzumab-DM1, which could replace its Herceptin remedy for women with advanced breast cancer. 07-07-2010 Tags breast, cancer, drug, roche
